Filed Pursuant to Rule 433
Registration Statement 333-141729
€900,000,000
4.750% Notes Due 2014
Pfizer Inc.
December 6, 2007
Pricing Term Sheet
| | | |
| Issuer: | | Pfizer Inc. |
| Size: | | €900,000,000 |
| Maturity: | | December 15, 2014 |
| Coupon: | | 4.750% annually, accruing from December 13, 2007 |
| Price to Public | | 99.871% of principal amount |
Interest Payment
Dates: | | December 15, commencing on December 15, 2008 |
| Optional Redemption: | | At any time for an amount equal to the principal amount of the notes redeemed plus a make-whole premium and accrued but unpaid interest to the redemption date |
| Make-Whole Premium: | | Bund, flat |
| Denominations: | | Minimum of€50,000 principal amount and integral multiples of€50,000 |
| Settlement Date: | | December 13, 2007 |
The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling Barclays Capital collect at +44 20 7773 9098 or JPMorgan collect at +44 20 7779 2468.
This pricing term sheet supplements the preliminary form of prospectus supplement issued by Pfizer Inc. on December 6, 2007 relating to its Prospectus dated March 30, 2007.
